SCHEMBL7222545

SCHEMBL7222545

Cc1ccc(-c2ccc3c(c2)C=C(C(=O)NCCCC2CCN(C4CCOCC4)CC2)CCO3)cc1

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 19/20 0.53
CCR2 P41597 2/20 0.44
CCR3 P51677 1/20 0.44
CCR7 P32248 1/20 0.39
CXCR3 P49682 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7223533 0.95 CCR5 (0.54) CCR5CCR2CCR3
SCHEMBL7215850 0.90 CCR5 (0.55) CCR5
SCHEMBL7167229 0.86 CCR5 (0.55) CCR5CCR2CCR7CXCR3
SCHEMBL7221463 0.84 GPR119 (0.54) CCR5CCR2CCR3
Hydrochloric Acid SCHEMBL7222856 0.84 CCR5 (0.50) CCR5CCR2CCR3
SCHEMBL7216461 0.80 CCR5 (0.52) CCR5CCR2CCR3
SCHEMBL7215746 0.79 GPR119 (0.51) CCR5
SCHEMBL7222422 0.79 CHRM4 (0.62) CCR5
SCHEMBL7221530 0.78 CCR5 (0.46) CCR5CXCR3
SCHEMBL7216317 0.75 KDM4E (0.50) CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed